Jump to content

PYC - PYC THERAPEUTICS LIMITED


ShareCafe

Recommended Posts

How's this for a scenario?

 

Binary data is a fail, price collapses,fancy new director gets the best fund in the world you've never heard of in on the game, then all of a sudden the real estate guy and Hockings disappear.

 

The deal was done by AMGN and FPRX.

Link to comment
Share on other sites

  • Replies 1.5k
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Posted Images

Gotta laugh at those HC pumptards. They're hamming up ARWR as if it's the next big thing and therefore good for PYC. People forget that when their SP collapsed to a dollar something and every drug trial they had underway worldwide got scratched. All that is except for one. The one underway at Auckland University Medical School and the associated hospital.

 

Now why is that? Like, what's ARWR to Auckland University? AU not even in the top 100 universities of the world.

 

Well, I don't actually know the answer but long time readers will remember Enumatit waxing on about how he bumped into OMD in the streets around Auckland University and how forthcoming he was with information about PYC trials when PYC was saying OMD was hard at work in the bowels of their lab. Burning the midnight oil even.

 

It's only logical one asks, wtf?

 

I don't know the answer to that either, but I do know ALNY have said ARWR have nothing important. Indeed, are nothing.

 

With binary data due in a week or so, right before Independence Day, it's also logical to conclude that if the HC pumptards are spruiking ARWR and PYC as one then the end is nigh.

 

So, ask yourself punk, is the real estate guy feeling lucky?

Link to comment
Share on other sites

So much great news. How are they going to pay for it all? Mr. Real Estate must be salivating at the prospects of it all.

 

June 29 (Reuters) - PYC Therapeutics Ltd (
) :

 

  • PYC THERAPEUTICS ANNOUNCES COMPREHENSIVE PRECLINICAL RESULTS DEMONSTRATING VP-002 PROGRAM'S POTENTIAL AS FIRST DISEASE MODIFYING THERAPY FOR AUTOSOMAL DOMINANT OPTIC ATROPHY
  • PYC THERAPEUTICS LTD - EXPECT TO FILE IND APPLICATION WITH FDA IN FIRST HALF OF 2023

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×
×
  • Create New...